Company

Seer, Inc.

Headquarters: Redwood City, CA, United States

Employees: 118

CEO: Dr. Omid C. Farokhzad M.D., Ph.D.

NASDAQ: SEER -0.43%

Market Cap

$106.2 Million

USD as of July 1, 2024

Market Cap History

Seer, Inc. market capitalization over time

Evolution of Seer, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Seer, Inc.

Detailed Description

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Seer, Inc. has the following listings and related stock indices.


Stock: NASDAQ: SEER wb_incandescent

Details

Headquarters:

3800 Bridge Parkway

Suite 102

Redwood City, CA 94065

United States

Phone: 650 453 0000